Oral Session 1-9D Biologic properties of AML cells

[OS1-9D-3] Low allelic ratio FLT3-ITD AML patients benefit from allogeneic transplantation in first remission

Feng-Ming Tien¹, Cheng-Hong Tsai^1,2, Hsin-An Hou¹, Sheng-Chuan Huang¹, Xiu-Wen Liao², Wen-Chien Chou³, Hwei-Feng Tien¹, Jih-Luh Tang^1,2 (1.Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan, 2.TaiCheng Stem Cell Therapy Center, National Taiwan University, Taipei, Taiwan, 3.Department of Laboratory medicine, National Taiwan University Hospital, Taipei, Taiwan)